The global amniotic products market size was valued at USD 0.7 billion in 2021 and is expected to surpass USD 1.5 billion by 2028. The market is estimated to expand at a CAGR of 8.2% during the forecast period, 2021–2028. Increasing target patient population, rising awareness programs about wound care, treatment & management, growing incidence of burn injuries, and increasing number of amniotic membrane transplantations are factors driving the amniotic products market.
Amniotic products, such as amniotic membrane and amniotic fluid products, are tissue derivatives that have been examined and used to treat a variety of orthopedic, ophthalmologic, and cosmetic diseases. These medicines are used to treat retinal detachments, corneal surface lesions, and other ophthalmologic conditions. Amniotic products, such as amniotic membranes, are used by plastic surgeons to treat chronic and acute burns. Amniotic product research has led to the development of treatments for a variety of orthopedic disorders, including osteoarthritis and plantar fasciitis, in the recent years. Amniotic products are being studied as a treatment for a variety of musculoskeletal issues.
Market Trends, Drivers, Restraints, and Opportunities:
- Increase in incidences of traumatic wounds and rise in orthopedic, ophthalmology, and cosmetic surgeries are expected to boost the market. The number of cases involving burn wounds and injuries has risen dramatically in the recent years. According to the World Health Organization (WHO), burns cause over 180000 deaths each year. The WHO's figures also show that over 1000000 people are moderately or seriously burned every year. These figures highlight the necessity for treatment to lessen the impact of wounds. The need for amniotic products is projected to rise as they are utilized to repair such wounds.
- Rising number of burn injuries around the globe and increasing awareness programs are anticipated to drive the global amniotic products market in the coming years.
- Growing venture capital funding and rising government investments are anticipated to drive the market in the coming years.
- Complications associated with the usage of amniotic membranes are expected to hinder the market during the forecast period.
- Increasing research in regenerative medicine across the globe is expected to offer lucrative opportunities for key players in the coming years.
Scope of the Report
The report on the global amniotic products market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Amniotic Products Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Product Type (Amniotic Suspensions and Amniotic Membranes), Type (Flowable and Non-flowable), Applications (Ophthalmology, Wound Care, Orthopedics, Prenatal Diagnosis, Periodontal, Regenerative Medicine, Stem Cell Biology, and Others), Adherence Type (Without Sutures and With Sutures), End-users (Hospitals, Research Institutes & Academics, Homecare, Clinics, and Others), Distribution Channels (Third-party Distributors and Direct Tenders)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players covered in the Report
|
MIMEDX., Smith & Nephew, Organogenesis Inc., Integra LifeSciences, AlloSource, Stryker, Katena Products. Inc., Skye Biologics Holdings, LLC, Surgenex, LLC, Ventris Medical, LLC, VIVEX Biologics, Inc., and LifeCell International Pvt. Ltd.
|
Global Amniotic Products Market Segment Insights
Based on the product type, the market is divided into amniotic suspensions and amniotic membranes. The amniotic membranes segment is expected to account for a key share of the market during the forecast period owing to the presence of a wide product portfolio provided by various companies.
In terms of type, the amniotic products market is segregated into flowable and non-flowable. The non-flowable segment is projected to account for a considerable share of the market during the forecast period, as it is commonly utilized in wound care and ophthalmology around the globe.
Based on applications, the market is divided into ophthalmology, wound care, orthopedics, prenatal diagnosis, periodontal, regenerative medicine, stem cell biology, and others. The wound care segment is anticipated to account for a significant share of the market during the forecast period. The anti-inflammatory qualities, bacteriostatic capabilities, wound protection, decreased scarring, pain reduction properties, and epithelialization, make amniotic membrane a desirable method of grafting for wounds. This, in turn, is expected to boost the segment growth in the coming years.
In terms of adherence type, the amniotic products market is bifurcated into without sutures and with sutures. The without sutures segment is projected to account for a considerable share of the market during the forecast period as it enables patient compliance, which is expected to boost the demand for amniotic products.
Based on end-uses, the market is classified as hospitals, research institutes & academics, home care, clinics, and others. The hospitals segment is projected to account for a considerable share of the market during the forecast period. Hospitals are primary healthcare provider for amniotic operations. The use of amniotic membrane for ophthalmic use or tendon and ligament repair is largely obtained in hospitals, as they offer reimbursements for the product, thus fueling the segment.
On the basis of distribution channels, the amniotic products market is bifurcated into third-party distributor and direct tender. The third-party distributor segment is projected to account for a considerable share of the market during the forecast period, due to the high demand for amniotic products in hospitals, stores, and clinics, which is expected to increase in the coming years.
Based on regions, the global market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. In 2020, North America held a dominant share of the market for owing to the high prevalence of target diseases, expanding awareness of advanced treatment options, growing elderly population in the region, and presence of a number of prominent market players. Conversely, Asia Pacific is estimated to expand at a high CAGR during the forecast period due to the presence of several developing countries in the region and expanding their regenerative medicine research. Quick approvals of novel regenerative products/medicines, and implementation of numerous initiatives and acts, are expected to propel the market.
Segments
Segments Covered in the Report:
By Product Type
- Amniotic Suspensions
- Amniotic Membranes
By Type
By Applications
- Ophthalmology
- Wound Care
- Orthopedics
- Prenatal Diagnosis
- Periodontal
- Regenerative Medicine
- Stem Cell Biology
- Others
By Adherence Type
- Without Sutures
- With Sutures
By End-Users
- Hospitals
- Research Institutes & Academics
- Homecare
- Clinics
- Others
By Distribution Channels
- Third-party Distributor
- Direct Tender
By Regions
- Asia Pacific
- North America
- Europe
- Latin America
- Middle East &Africa
By Key Players
- MIMEDX.
- Smith & Nephew
- Organogenesis Inc.
- Integra LifeSciences
- AlloSource
- Stryker
- Katena Products. Inc.
- Skye Biologics Holdings, LLC
- Surgenex, LLC
- Ventris Medical, LLC
- VIVEX Biologics, Inc.
- LifeCell International Pvt. Ltd.
Competitive Landscape
Players in the global amniotic products market are MIMEDX., Smith & Nephew, Organogenesis Inc., Integra LifeSciences, AlloSource, Stryker, Katena Products. Inc., Skye Biologics Holdings, LLC, Surgenex, LLC, Ventris Medical, LLC, VIVEX Biologics, Inc., and LifeCell International Pvt. Ltd.
Request For Customization
Enquiry Before Buying
Speak With Analyst
